Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis Adnan Malik; Sadia Javaid; Muhammad Imran Malik; Shahbaz Qureshi;

Clinical and molecular implications of antipsychotics in MASLD Celina Gonzalez; Misael Uribe; Norberto C. Chavez-Tapia;

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience Thanikan Sukaram; Soe Thiha Maung; Yuda Chongpison; Tassanan Jaihan; Chonlada Phathong; Roongruedee Chaiteerakij;